Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Metoda Dodic-Fikfak"'
Publikováno v:
Safety and Health at Work, Vol 13, Iss , Pp S251- (2022)
Externí odkaz:
https://doaj.org/article/cbd30602d2e34b949b8a4cf574be7dda
Publikováno v:
Radiology and Oncology, Vol 55, Iss 2, Pp 179-186 (2021)
Radiology and Oncology
Radiology and Oncology
Background The study investigated the influence of GCLC, GCLM, GSTM1, GSTT1 and GSTP1 polymorphisms, as well as the influence of interactions between polymorphism and interactions between polymorphisms and asbestos exposure, on the risk of developing
Publikováno v:
Radiology and Oncology, Vol 54, Iss 1, Pp 86-95 (2020)
Radiology and oncology, str. 86-95, IX : Ilustr., Vol. 54, no. 1, Mar. 2020
COBISS-ID: 32649472
Radiology and Oncology
Radiology and oncology, str. 86-95, IX : Ilustr., Vol. 54, no. 1, Mar. 2020
COBISS-ID: 32649472
Radiology and Oncology
Background Asbestos exposure is associated with increased risk of several diseases, including malignant mesothelioma (MM). Cell surface glycoprotein mesothelin is overexpressed in MM and serum soluble mesothelin-related peptides (SMRP) were already p
Publikováno v:
Radiology and Oncology, Vol 52, Iss 1, Pp 105-111 (2018)
Radiology and oncology (Ljubljana)
Radiology and Oncology
Radiology and oncology (Ljubljana)
Radiology and Oncology
Background Malignant mesothelioma is a rare cancer with poor outcome, associated with asbestos exposure. Reactive oxygen species may play an important role in the mechanism of carcinogenesis; therefore, genetic variability in antioxidative defence ma
Autor:
Katja Goričar, Vita Dolžan, Cita Zupanc, Metoda Dodic Fikfak, Danijela Štrbac, Alenka Franko, Viljem Kovač
Publikováno v:
Journal of clinical medicine, vol. 10, no. 21, 4875, 2021.
Journal of Clinical Medicine
Volume 10
Issue 21
Journal of Clinical Medicine, Vol 10, Iss 4875, p 4875 (2021)
Journal of Clinical Medicine
Volume 10
Issue 21
Journal of Clinical Medicine, Vol 10, Iss 4875, p 4875 (2021)
The early diagnosis of malignant mesothelioma (MM) could improve the prognosis of MM patients. To confirm an MM diagnosis, an immunohistochemical analysis of several tumor tissue markers, including calretinin, is currently required. Our aim is to eva
Publikováno v:
Journal of Medical Biochemistry, Vol 39, Iss 1, Pp 91-99 (2020)
J Med Biochem
J Med Biochem
This study aimed to investigate the association between NLRP3 rs35829419 and CARD8 rs2043211 polymorphisms and the risk of developing pleural plaques, asbestosis, and malignant mesothelioma (MM), and to study the influence of the interactions between
Publikováno v:
Respiratory Disorders.
Introduction Although the causal relationship between asbestosis and asbestos exposure has been well proved, little is known about the genetic factors that may influence the development of this disease. This study investigated the influence of gene-g
Publikováno v:
Journal of Thoracic Oncology. 7:1609-1617
IntroductionGenetic polymorphisms that affect DNA repair capacity can modulate the efficacy and toxicity of cytotoxic agents. Therefore, the aim of our study was to evaluate the influence of genetic variability in DNA repair genes on treatment outcom
Publikováno v:
Disease Markers, Vol 32, Iss 2, Pp 123-131 (2012)
Disease markers
Disease markers
Soluble mesothelin-related peptides (SMRP) are a potential tumor marker for malignant mesothelioma. The aim of this study was to determine the differences in SMRP levels in patients with malignant mesothelioma before treatment and in various response